Deutsche Bank’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$985K Sell
195,495
-12,795
-6% -$64.5K ﹤0.01% 2087
2025
Q1
$1.35M Sell
208,290
-8,444
-4% -$54.7K ﹤0.01% 1970
2024
Q4
$1.59M Buy
216,734
+27,515
+15% +$202K ﹤0.01% 1965
2024
Q3
$1.42M Buy
189,219
+143,182
+311% +$1.07M ﹤0.01% 1924
2024
Q2
$410K Buy
46,037
+4,572
+11% +$40.7K ﹤0.01% 2394
2024
Q1
$420K Buy
41,465
+4
+0% +$41 ﹤0.01% 2398
2023
Q4
$417K Sell
41,461
-1,015
-2% -$10.2K ﹤0.01% 2419
2023
Q3
$398K Buy
42,476
+5,219
+14% +$48.9K ﹤0.01% 2291
2023
Q2
$914K Sell
37,257
-76,950
-67% -$1.89M ﹤0.01% 2045
2023
Q1
$2.66M Sell
114,207
-28,880
-20% -$672K ﹤0.01% 1520
2022
Q4
$3.62M Buy
143,087
+103,692
+263% +$2.62M ﹤0.01% 1353
2022
Q3
$759K Sell
39,395
-3,845
-9% -$74.1K ﹤0.01% 2139
2022
Q2
$1.1M Sell
43,240
-1,238
-3% -$31.5K ﹤0.01% 2112
2022
Q1
$1.14M Sell
44,478
-3,748
-8% -$96.4K ﹤0.01% 2252
2021
Q4
$2.02M Sell
48,226
-1,676
-3% -$70.2K ﹤0.01% 1971
2021
Q3
$2.17M Buy
49,902
+2,762
+6% +$120K ﹤0.01% 2030
2021
Q2
$2.23M Buy
47,140
+5,310
+13% +$251K ﹤0.01% 2117
2021
Q1
$2.15M Sell
41,830
-3,898
-9% -$200K ﹤0.01% 2114
2020
Q4
$1.23M Buy
45,728
+14,925
+48% +$400K ﹤0.01% 2303
2020
Q3
$1.06M Buy
30,803
+7,410
+32% +$254K ﹤0.01% 2150
2020
Q2
$958K Buy
23,393
+20,902
+839% +$856K ﹤0.01% 2246
2020
Q1
$86K Sell
2,491
-320
-11% -$11K ﹤0.01% 3262
2019
Q4
$34K Buy
+2,811
New +$34K ﹤0.01% 3979